Copyright Reports & Markets. All rights reserved.

Global Pacemakers and Cardiac Resynchronization Therapy Devices Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Pacemakers and Cardiac Resynchronization Therapy Devices Consumption Value by Type: 2021 Versus 2025 Versus 2032
    • 1.3.2 Pacemaker
    • 1.3.3 ICD
    • 1.3.4 CRT
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Pacemakers and Cardiac Resynchronization Therapy Devices Consumption Value by Application: 2021 Versus 2025 Versus 2032
    • 1.4.2 Bradycardia
    • 1.4.3 Tachycardia
    • 1.4.4 Heart Failure
    • 1.4.5 Others
  • 1.5 Global Pacemakers and Cardiac Resynchronization Therapy Devices Market Size & Forecast
    • 1.5.1 Global Pacemakers and Cardiac Resynchronization Therapy Devices Consumption Value (2021 & 2025 & 2032)
    • 1.5.2 Global Pacemakers and Cardiac Resynchronization Therapy Devices Sales Quantity (2021-2032)
    • 1.5.3 Global Pacemakers and Cardiac Resynchronization Therapy Devices Average Price (2021-2032)

2 Manufacturers Profiles

  • 2.1 Medtronic
    • 2.1.1 Medtronic Details
    • 2.1.2 Medtronic Major Business
    • 2.1.3 Medtronic Pacemakers and Cardiac Resynchronization Therapy Devices Product and Services
    • 2.1.4 Medtronic Pacemakers and Cardiac Resynchronization Therapy Devices Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.1.5 Medtronic Recent Developments/Updates
  • 2.2 St. Jude Medical (Abbott)
    • 2.2.1 St. Jude Medical (Abbott) Details
    • 2.2.2 St. Jude Medical (Abbott) Major Business
    • 2.2.3 St. Jude Medical (Abbott) Pacemakers and Cardiac Resynchronization Therapy Devices Product and Services
    • 2.2.4 St. Jude Medical (Abbott) Pacemakers and Cardiac Resynchronization Therapy Devices Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.2.5 St. Jude Medical (Abbott) Recent Developments/Updates
  • 2.3 Boston Scientific
    • 2.3.1 Boston Scientific Details
    • 2.3.2 Boston Scientific Major Business
    • 2.3.3 Boston Scientific Pacemakers and Cardiac Resynchronization Therapy Devices Product and Services
    • 2.3.4 Boston Scientific Pacemakers and Cardiac Resynchronization Therapy Devices Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.3.5 Boston Scientific Recent Developments/Updates
  • 2.4 Biotronik
    • 2.4.1 Biotronik Details
    • 2.4.2 Biotronik Major Business
    • 2.4.3 Biotronik Pacemakers and Cardiac Resynchronization Therapy Devices Product and Services
    • 2.4.4 Biotronik Pacemakers and Cardiac Resynchronization Therapy Devices Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.4.5 Biotronik Recent Developments/Updates
  • 2.5 MicroPort
    • 2.5.1 MicroPort Details
    • 2.5.2 MicroPort Major Business
    • 2.5.3 MicroPort Pacemakers and Cardiac Resynchronization Therapy Devices Product and Services
    • 2.5.4 MicroPort Pacemakers and Cardiac Resynchronization Therapy Devices Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.5.5 MicroPort Recent Developments/Updates
  • 2.6 Medico
    • 2.6.1 Medico Details
    • 2.6.2 Medico Major Business
    • 2.6.3 Medico Pacemakers and Cardiac Resynchronization Therapy Devices Product and Services
    • 2.6.4 Medico Pacemakers and Cardiac Resynchronization Therapy Devices Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.6.5 Medico Recent Developments/Updates
  • 2.7 Lepu (Qinming Medical)
    • 2.7.1 Lepu (Qinming Medical) Details
    • 2.7.2 Lepu (Qinming Medical) Major Business
    • 2.7.3 Lepu (Qinming Medical) Pacemakers and Cardiac Resynchronization Therapy Devices Product and Services
    • 2.7.4 Lepu (Qinming Medical) Pacemakers and Cardiac Resynchronization Therapy Devices Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.7.5 Lepu (Qinming Medical) Recent Developments/Updates
  • 2.8 IMZ
    • 2.8.1 IMZ Details
    • 2.8.2 IMZ Major Business
    • 2.8.3 IMZ Pacemakers and Cardiac Resynchronization Therapy Devices Product and Services
    • 2.8.4 IMZ Pacemakers and Cardiac Resynchronization Therapy Devices Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.8.5 IMZ Recent Developments/Updates
  • 2.9 Cardioelectronica
    • 2.9.1 Cardioelectronica Details
    • 2.9.2 Cardioelectronica Major Business
    • 2.9.3 Cardioelectronica Pacemakers and Cardiac Resynchronization Therapy Devices Product and Services
    • 2.9.4 Cardioelectronica Pacemakers and Cardiac Resynchronization Therapy Devices Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.9.5 Cardioelectronica Recent Developments/Updates
  • 2.10 Pacetronix
    • 2.10.1 Pacetronix Details
    • 2.10.2 Pacetronix Major Business
    • 2.10.3 Pacetronix Pacemakers and Cardiac Resynchronization Therapy Devices Product and Services
    • 2.10.4 Pacetronix Pacemakers and Cardiac Resynchronization Therapy Devices Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.10.5 Pacetronix Recent Developments/Updates

3 Competitive Environment: Pacemakers and Cardiac Resynchronization Therapy Devices by Manufacturer

  • 3.1 Global Pacemakers and Cardiac Resynchronization Therapy Devices Sales Quantity by Manufacturer (2021-2026)
  • 3.2 Global Pacemakers and Cardiac Resynchronization Therapy Devices Revenue by Manufacturer (2021-2026)
  • 3.3 Global Pacemakers and Cardiac Resynchronization Therapy Devices Average Price by Manufacturer (2021-2026)
  • 3.4 Market Share Analysis (2025)
    • 3.4.1 Producer Shipments of Pacemakers and Cardiac Resynchronization Therapy Devices by Manufacturer Revenue ($MM) and Market Share (%): 2025
    • 3.4.2 Top 3 Pacemakers and Cardiac Resynchronization Therapy Devices Manufacturer Market Share in 2025
    • 3.4.3 Top 6 Pacemakers and Cardiac Resynchronization Therapy Devices Manufacturer Market Share in 2025
  • 3.5 Pacemakers and Cardiac Resynchronization Therapy Devices Market: Overall Company Footprint Analysis
    • 3.5.1 Pacemakers and Cardiac Resynchronization Therapy Devices Market: Region Footprint
    • 3.5.2 Pacemakers and Cardiac Resynchronization Therapy Devices Market: Company Product Type Footprint
    • 3.5.3 Pacemakers and Cardiac Resynchronization Therapy Devices Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Pacemakers and Cardiac Resynchronization Therapy Devices Market Size by Region
    • 4.1.1 Global Pacemakers and Cardiac Resynchronization Therapy Devices Sales Quantity by Region (2021-2032)
    • 4.1.2 Global Pacemakers and Cardiac Resynchronization Therapy Devices Consumption Value by Region (2021-2032)
    • 4.1.3 Global Pacemakers and Cardiac Resynchronization Therapy Devices Average Price by Region (2021-2032)
  • 4.2 North America Pacemakers and Cardiac Resynchronization Therapy Devices Consumption Value (2021-2032)
  • 4.3 Europe Pacemakers and Cardiac Resynchronization Therapy Devices Consumption Value (2021-2032)
  • 4.4 Asia-Pacific Pacemakers and Cardiac Resynchronization Therapy Devices Consumption Value (2021-2032)
  • 4.5 South America Pacemakers and Cardiac Resynchronization Therapy Devices Consumption Value (2021-2032)
  • 4.6 Middle East & Africa Pacemakers and Cardiac Resynchronization Therapy Devices Consumption Value (2021-2032)

5 Market Segment by Type

  • 5.1 Global Pacemakers and Cardiac Resynchronization Therapy Devices Sales Quantity by Type (2021-2032)
  • 5.2 Global Pacemakers and Cardiac Resynchronization Therapy Devices Consumption Value by Type (2021-2032)
  • 5.3 Global Pacemakers and Cardiac Resynchronization Therapy Devices Average Price by Type (2021-2032)

6 Market Segment by Application

  • 6.1 Global Pacemakers and Cardiac Resynchronization Therapy Devices Sales Quantity by Application (2021-2032)
  • 6.2 Global Pacemakers and Cardiac Resynchronization Therapy Devices Consumption Value by Application (2021-2032)
  • 6.3 Global Pacemakers and Cardiac Resynchronization Therapy Devices Average Price by Application (2021-2032)

7 North America

  • 7.1 North America Pacemakers and Cardiac Resynchronization Therapy Devices Sales Quantity by Type (2021-2032)
  • 7.2 North America Pacemakers and Cardiac Resynchronization Therapy Devices Sales Quantity by Application (2021-2032)
  • 7.3 North America Pacemakers and Cardiac Resynchronization Therapy Devices Market Size by Country
    • 7.3.1 North America Pacemakers and Cardiac Resynchronization Therapy Devices Sales Quantity by Country (2021-2032)
    • 7.3.2 North America Pacemakers and Cardiac Resynchronization Therapy Devices Consumption Value by Country (2021-2032)
    • 7.3.3 United States Market Size and Forecast (2021-2032)
    • 7.3.4 Canada Market Size and Forecast (2021-2032)
    • 7.3.5 Mexico Market Size and Forecast (2021-2032)

8 Europe

  • 8.1 Europe Pacemakers and Cardiac Resynchronization Therapy Devices Sales Quantity by Type (2021-2032)
  • 8.2 Europe Pacemakers and Cardiac Resynchronization Therapy Devices Sales Quantity by Application (2021-2032)
  • 8.3 Europe Pacemakers and Cardiac Resynchronization Therapy Devices Market Size by Country
    • 8.3.1 Europe Pacemakers and Cardiac Resynchronization Therapy Devices Sales Quantity by Country (2021-2032)
    • 8.3.2 Europe Pacemakers and Cardiac Resynchronization Therapy Devices Consumption Value by Country (2021-2032)
    • 8.3.3 Germany Market Size and Forecast (2021-2032)
    • 8.3.4 France Market Size and Forecast (2021-2032)
    • 8.3.5 United Kingdom Market Size and Forecast (2021-2032)
    • 8.3.6 Russia Market Size and Forecast (2021-2032)
    • 8.3.7 Italy Market Size and Forecast (2021-2032)

9 Asia-Pacific

  • 9.1 Asia-Pacific Pacemakers and Cardiac Resynchronization Therapy Devices Sales Quantity by Type (2021-2032)
  • 9.2 Asia-Pacific Pacemakers and Cardiac Resynchronization Therapy Devices Sales Quantity by Application (2021-2032)
  • 9.3 Asia-Pacific Pacemakers and Cardiac Resynchronization Therapy Devices Market Size by Region
    • 9.3.1 Asia-Pacific Pacemakers and Cardiac Resynchronization Therapy Devices Sales Quantity by Region (2021-2032)
    • 9.3.2 Asia-Pacific Pacemakers and Cardiac Resynchronization Therapy Devices Consumption Value by Region (2021-2032)
    • 9.3.3 China Market Size and Forecast (2021-2032)
    • 9.3.4 Japan Market Size and Forecast (2021-2032)
    • 9.3.5 South Korea Market Size and Forecast (2021-2032)
    • 9.3.6 India Market Size and Forecast (2021-2032)
    • 9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
    • 9.3.8 Australia Market Size and Forecast (2021-2032)

10 South America

  • 10.1 South America Pacemakers and Cardiac Resynchronization Therapy Devices Sales Quantity by Type (2021-2032)
  • 10.2 South America Pacemakers and Cardiac Resynchronization Therapy Devices Sales Quantity by Application (2021-2032)
  • 10.3 South America Pacemakers and Cardiac Resynchronization Therapy Devices Market Size by Country
    • 10.3.1 South America Pacemakers and Cardiac Resynchronization Therapy Devices Sales Quantity by Country (2021-2032)
    • 10.3.2 South America Pacemakers and Cardiac Resynchronization Therapy Devices Consumption Value by Country (2021-2032)
    • 10.3.3 Brazil Market Size and Forecast (2021-2032)
    • 10.3.4 Argentina Market Size and Forecast (2021-2032)

11 Middle East & Africa

  • 11.1 Middle East & Africa Pacemakers and Cardiac Resynchronization Therapy Devices Sales Quantity by Type (2021-2032)
  • 11.2 Middle East & Africa Pacemakers and Cardiac Resynchronization Therapy Devices Sales Quantity by Application (2021-2032)
  • 11.3 Middle East & Africa Pacemakers and Cardiac Resynchronization Therapy Devices Market Size by Country
    • 11.3.1 Middle East & Africa Pacemakers and Cardiac Resynchronization Therapy Devices Sales Quantity by Country (2021-2032)
    • 11.3.2 Middle East & Africa Pacemakers and Cardiac Resynchronization Therapy Devices Consumption Value by Country (2021-2032)
    • 11.3.3 Turkey Market Size and Forecast (2021-2032)
    • 11.3.4 Egypt Market Size and Forecast (2021-2032)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
    • 11.3.6 South Africa Market Size and Forecast (2021-2032)

12 Market Dynamics

  • 12.1 Pacemakers and Cardiac Resynchronization Therapy Devices Market Drivers
  • 12.2 Pacemakers and Cardiac Resynchronization Therapy Devices Market Restraints
  • 12.3 Pacemakers and Cardiac Resynchronization Therapy Devices Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Pacemakers and Cardiac Resynchronization Therapy Devices and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Pacemakers and Cardiac Resynchronization Therapy Devices
  • 13.3 Pacemakers and Cardiac Resynchronization Therapy Devices Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Pacemakers and Cardiac Resynchronization Therapy Devices Typical Distributors
  • 14.3 Pacemakers and Cardiac Resynchronization Therapy Devices Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global Pacemakers and Cardiac Resynchronization Therapy Devices market size was valued at US$ 12570 million in 2025 and is forecast to a readjusted size of US$ 15460 million by 2032 with a CAGR of 3.0% during review period.
    Cardiac Rhythm Management Device is a medical device which uses electrical impulses, delivered by electrodes contracting the heart muscles, to regulate the beating of the heart.
    A cardiac rhythm management device (CRMD) refers to any permanently implanted cardiac pacemaker or any implantable cardioverter-defibrillator (ICD). The term CRMD also refers to any cardiac resynchronization device. The term CRT refers to a CRMD that provides cardiac resynchronization therapy using biventricular pacing techniques.
    North America is the largest Pacemakers and Cardiac Resynchronization Therapy Devices market with about 49% market share. Europe is follower, accounting for about 26% market share.
    The key players are Medtronic, St. Jude Medical (Abbott), Boston Scientific, Biotronik, MicroPort, Medico, Lepu (Qinming Medical), IMZ, Cardioelectronica, Pacetronix etc. Top 3 companies occupied about 89% market share.
    This report is a detailed and comprehensive analysis for global Pacemakers and Cardiac Resynchronization Therapy Devices market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
    Key Features:
    Global Pacemakers and Cardiac Resynchronization Therapy Devices market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (USD/Unit), 2021-2032
    Global Pacemakers and Cardiac Resynchronization Therapy Devices market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (USD/Unit), 2021-2032
    Global Pacemakers and Cardiac Resynchronization Therapy Devices market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (USD/Unit), 2021-2032
    Global Pacemakers and Cardiac Resynchronization Therapy Devices market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (USD/Unit), 2021-2026
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for Pacemakers and Cardiac Resynchronization Therapy Devices
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global Pacemakers and Cardiac Resynchronization Therapy Devices market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Medtronic, St. Jude Medical (Abbott), Boston Scientific, Biotronik, MicroPort, Medico, Lepu (Qinming Medical), IMZ, Cardioelectronica, Pacetronix, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
    Market Segmentation
    Pacemakers and Cardiac Resynchronization Therapy Devices market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    Pacemaker
    ICD
    CRT
    Market segment by Application
    Bradycardia
    Tachycardia
    Heart Failure
    Others
    Major players covered
    Medtronic
    St. Jude Medical (Abbott)
    Boston Scientific
    Biotronik
    MicroPort
    Medico
    Lepu (Qinming Medical)
    IMZ
    Cardioelectronica
    Pacetronix
    Market segment by region, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 15 chapters:
    Chapter 1, to describe Pacemakers and Cardiac Resynchronization Therapy Devices product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top manufacturers of Pacemakers and Cardiac Resynchronization Therapy Devices, with price, sales quantity, revenue, and global market share of Pacemakers and Cardiac Resynchronization Therapy Devices from 2021 to 2026.
    Chapter 3, the Pacemakers and Cardiac Resynchronization Therapy Devices competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
    Chapter 4, the Pacemakers and Cardiac Resynchronization Therapy Devices breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
    Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
    Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Pacemakers and Cardiac Resynchronization Therapy Devices market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
    Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
    Chapter 13, the key raw materials and key suppliers, and industry chain of Pacemakers and Cardiac Resynchronization Therapy Devices.
    Chapter 14 and 15, to describe Pacemakers and Cardiac Resynchronization Therapy Devices sales channel, distributors, customers, research findings and conclusion.

    Buy now